Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Boulton S, Poutou J, Martin NT, Azad T, Singaravelu R, Crupi MJF, Jamieson T, He X, Marius R, Petryk J, Tanese de Souza C, Austin B, Taha Z, Whelan J, Khan ST, Pelin A, Rezaei R, Surendran A, Tucker S, Fekete EEF, Dave J, Diallo JS, Auer R, Angel JB, Cameron DW, Cailhier JF, Lapointe R, Potts K, Mahoney DJ, Bell JC, Ilkow CS.
Boulton S, et al. Among authors: whelan j.
Mol Ther. 2022 May 4;30(5):1885-1896. doi: 10.1016/j.ymthe.2021.10.008. Epub 2021 Oct 20.
Mol Ther. 2022.
PMID: 34687845
Free PMC article.